Wallet Pharma Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
- Paid Up Capital ₹ 34.00 Cr
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -76.45%
- Profit Growth 114.30%
- Ebitda 73.79%
- Net Worth 9.83%
- Total Assets 11.04%
About Wallet Pharma
Wallet Pharma Private Limited (WPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 December 2015 (Nine years and two months 19 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 100.00 Cr and a paid-up capital of Rs 34.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Wallet Pharma Private Limited India is Reethu Chepuri as COMPANY SECRETARY. Chandra Tumuluru, Palleswara Govada, and Chittajallu Gopalakrishna serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100TG2015PTC102108
- Company No.
102108
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Dec 2015
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Wallet Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Reethu Chepuri | Company Secretary | 27-May-2019 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandra Tumuluru  | Director | 11-Dec-2023 | Current |
| Palleswara Govada | Director | 07-Dec-2015 | Current |
| Chittajallu Gopalakrishna | Director | 20-Jun-2017 | Current |
Financial Performance of Wallet Pharma.
Wallet Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 76.45% decrease. The company also saw a substantial improvement in profitability, with a 114.3% increase in profit. The company's net worth moved up by a moderate rise of 9.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wallet Pharma?
In 2020, Wallet Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hetero Marbles Private LimitedChandra Tumuluru is a mutual person
Hetero Biopharma LimitedChandra Tumuluru is a mutual person
Cirex Pharmaceuticals Private LimitedChandra Tumuluru is a mutual person
Hoster Labs Private LimitedChandra Tumuluru is a mutual person
- Honour Infra Estates Limited
Chandra Tumuluru is a mutual person
Asphar Research Labs Private LimitedChandra Tumuluru is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wallet Pharma?
Unlock and access historical data on people associated with Wallet Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wallet Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wallet Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.